Epigenetics and Disease: Pharmaceutical Opportunities: 67 (Progress in Drug Research)

by SusanM.Gasser (Editor), EnLi (Editor)

New
Hardcover
2010
$353.60

Epigentic alterations, unlike genetic, are, in principle, amenable to pharmacological intervention, and a few of those drugs are currently undergoing clinical trial. This volume highlights the results of those studies.

Synopsis

Epigentic alterations, unlike genetic, are, in principle, amenable to pharmacological intervention, and a few of those drugs are currently undergoing clinical trial. This volume highlights the results of those studies.

$353.60

Quantity

20+ in stock

More Information

Format: Hardcover
Pages: 270
Edition: 1st Edition.
Publisher: Springer Basel
Published: 02 Oct 2010
ISBN 10: 3764389885
ISBN 13: 9783764389888

Epigenetics and Disease: Pharmaceutical Opportunities: 67 (Progress in Drug Research)

New

$353.60

Synopsis

$353.60

More Information